Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant benefits » significant effects (Expand Search)
significant co » significant _ (Expand Search), significant gap (Expand Search), significant factor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant benefits » significant effects (Expand Search)
significant co » significant _ (Expand Search), significant gap (Expand Search), significant factor (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
7
-
8
-
9
-
10
-
11
-
12
-
13
IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1.
Published 2025Subjects: -
14
IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1.
Published 2025Subjects: -
15
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
16
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
17
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
18
-
19
-
20